Login / Signup

Syringaresinol inhibits cardiorenal fibrosis through HSP90 in a cardiorenal syndrome type 2.

Jianjie WangJianqin ZouCheng ZhaoHan YuJiajia TengLei Dong
Published in: Human & experimental toxicology (2023)
Syringaresinol targets HSP90 to suppress CRS2-induced cardiorenal fibrosis, providing a promising therapeutic drug for CRS2.
Keyphrases
  • heat shock protein
  • heat shock
  • heat stress
  • high glucose
  • drug induced
  • diabetic rats
  • liver fibrosis
  • case report